Compile Data Set for Download or QSAR
Report error Found 42 Enz. Inhib. hit(s) with all data for entry = 50013099
TargetCoagulation factor VII(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126575(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-[1-(3-oxo-...)
Affinity DataKi:  23nMAssay Description:In vitro inhibitory activity against coagulation factor VII (fVIIa)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126571(N-[(S)-1-(3-Bromo-phenyl)-ethyl]-2-[3-(4-carbamimi...)
Affinity DataKi:  27nMAssay Description:In vitro inhibitory activity against coagulation factor VII (fVIIa)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126572(N-[1-(2,4-Bis-trifluoromethyl-phenyl)-ethyl]-2-[3-...)
Affinity DataKi:  27nMAssay Description:In vitro inhibitory activity against coagulation factor VII (fVIIa)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126579(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-[1-((S)-3-...)
Affinity DataKi:  35nMAssay Description:In vitro inhibitory activity against coagulation factor VII (fVIIa)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126570(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-[(S)-1-(2,...)
Affinity DataKi:  67nMAssay Description:In vitro inhibitory activity against coagulation factor VII (fVIIa)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126574(N-[(S)-1-(3-Bromo-phenyl)-ethyl]-2-[3-(4-carbamimi...)
Affinity DataKi:  120nMAssay Description:In vitro inhibitory activity against coagulation factor VII (fVIIa)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126585(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-((S)-1-phe...)
Affinity DataKi:  430nMAssay Description:In vitro inhibitory activity against coagulation factor VII (fVIIa)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126576(2-[3-(4-Carbamimidoyl-3-fluoro-phenyl)-ureido]-N-[...)
Affinity DataKi:  470nMAssay Description:In vitro inhibitory activity against coagulation factor VII (fVIIa)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126587((S)-4-[(S)-1-(3-Bromo-phenyl)-ethylcarbamoyl]-4-[3...)
Affinity DataKi:  540nMAssay Description:In vitro inhibitory activity against coagulation factor VII (fVIIa)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126577(N-Benzhydryl-2-[3-(4-carbamimidoyl-phenyl)-ureido]...)
Affinity DataKi:  730nMAssay Description:In vitro inhibitory activity against coagulation factor VII (fVIIa)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126582(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-(3,4-dichl...)
Affinity DataKi:  970nMAssay Description:In vitro inhibitory activity against coagulation factor VII (fVIIa)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126582(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-(3,4-dichl...)
Affinity DataKi:  1.45E+3nMAssay Description:In vitro inhibitory activity against zymogen coagulation factor (fXa)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126573(N-(3-Bromo-benzyl)-2-[3-(4-carbamimidoyl-phenyl)-u...)
Affinity DataKi:  1.51E+3nMAssay Description:In vitro inhibitory activity against coagulation factor VII (fVIIa)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126583(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-(4-dimethy...)
Affinity DataKi:  1.94E+3nMAssay Description:In vitro inhibitory activity against coagulation factor VII (fVIIa)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126580(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-(3-chloro-...)
Affinity DataKi:  2.17E+3nMAssay Description:In vitro inhibitory activity against coagulation factor VII (fVIIa)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126588(N-[(S)-1-(3-Bromo-phenyl)-ethyl]-2-[3-(4-carbamimi...)
Affinity DataKi:  3.20E+3nMAssay Description:In vitro inhibitory activity against coagulation factor VII (fVIIa)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126578(N-[(S)-1-(3-Bromo-phenyl)-ethyl]-2-[3-(4-carbamimi...)
Affinity DataKi:  3.76E+3nMAssay Description:In vitro inhibitory activity against coagulation factor VII (fVIIa)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126581(2-[3-(4-Carbamimidoyl-3-chloro-phenyl)-ureido]-N-[...)
Affinity DataKi:  3.94E+3nMAssay Description:In vitro inhibitory activity against coagulation factor VII (fVIIa)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126568(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-(1-methyl-...)
Affinity DataKi:  7.62E+3nMAssay Description:In vitro inhibitory activity against coagulation factor VII (fVIIa)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126573(N-(3-Bromo-benzyl)-2-[3-(4-carbamimidoyl-phenyl)-u...)
Affinity DataKi:  7.80E+3nMAssay Description:In vitro inhibitory activity against zymogen coagulation factor (fXa)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126572(N-[1-(2,4-Bis-trifluoromethyl-phenyl)-ethyl]-2-[3-...)
Affinity DataKi: >1.00E+4nMAssay Description:In vitro inhibitory activity against zymogen coagulation factor (fXa)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126568(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-(1-methyl-...)
Affinity DataKi: >1.00E+4nMAssay Description:In vitro inhibitory activity against zymogen coagulation factor (fXa)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126585(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-((S)-1-phe...)
Affinity DataKi: >1.00E+4nMAssay Description:In vitro inhibitory activity against zymogen coagulation factor (fXa)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126569(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-((R)-1-phe...)
Affinity DataKi: >1.00E+4nMAssay Description:In vitro inhibitory activity against zymogen coagulation factor (fXa)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126570(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-[(S)-1-(2,...)
Affinity DataKi: >1.00E+4nMAssay Description:In vitro inhibitory activity against zymogen coagulation factor (fXa)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126575(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-[1-(3-oxo-...)
Affinity DataKi: >1.00E+4nMAssay Description:In vitro inhibitory activity against zymogen coagulation factor (fXa)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126579(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-[1-((S)-3-...)
Affinity DataKi: >1.00E+4nMAssay Description:In vitro inhibitory activity against zymogen coagulation factor (fXa)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126571(N-[(S)-1-(3-Bromo-phenyl)-ethyl]-2-[3-(4-carbamimi...)
Affinity DataKi: >1.00E+4nMAssay Description:In vitro inhibitory activity against zymogen coagulation factor (fXa)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProthrombin(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126582(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-(3,4-dichl...)
Affinity DataKi:  1.01E+4nMAssay Description:In vitro inhibitory activity against thrombinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProthrombin(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126570(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-[(S)-1-(2,...)
Affinity DataKi:  1.12E+4nMAssay Description:In vitro inhibitory activity against thrombinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProthrombin(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126571(N-[(S)-1-(3-Bromo-phenyl)-ethyl]-2-[3-(4-carbamimi...)
Affinity DataKi:  1.59E+4nMAssay Description:In vitro inhibitory activity against thrombinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProthrombin(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126575(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-[1-(3-oxo-...)
Affinity DataKi:  1.64E+4nMAssay Description:In vitro inhibitory activity against thrombinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProthrombin(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126579(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-[1-((S)-3-...)
Affinity DataKi:  1.82E+4nMAssay Description:In vitro inhibitory activity against thrombinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126569(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-((R)-1-phe...)
Affinity DataKi:  2.02E+4nMAssay Description:In vitro inhibitory activity against coagulation factor VII (fVIIa)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126586(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-(4-dimethy...)
Affinity DataKi:  2.09E+4nMAssay Description:In vitro inhibitory activity against coagulation factor VII (fVIIa)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126584(N-[(R)-1-(3-Bromo-phenyl)-ethyl]-2-[3-(4-carbamimi...)
Affinity DataKi:  3.10E+4nMAssay Description:In vitro inhibitory activity against coagulation factor VII (fVIIa)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126567((S)-2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-(3,4-d...)
Affinity DataKi:  4.58E+4nMAssay Description:In vitro inhibitory activity against coagulation factor VII (fVIIa)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProthrombin(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126568(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-(1-methyl-...)
Affinity DataKi: >5.00E+4nMAssay Description:In vitro inhibitory activity against thrombinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProthrombin(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126573(N-(3-Bromo-benzyl)-2-[3-(4-carbamimidoyl-phenyl)-u...)
Affinity DataKi: >5.00E+4nMAssay Description:In vitro inhibitory activity against thrombinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProthrombin(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126569(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-((R)-1-phe...)
Affinity DataKi: >5.00E+4nMAssay Description:In vitro inhibitory activity against thrombinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProthrombin(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126585(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-((S)-1-phe...)
Affinity DataKi:  5.07E+4nMAssay Description:In vitro inhibitory activity against thrombinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProthrombin(Human)
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50126572(N-[1-(2,4-Bis-trifluoromethyl-phenyl)-ethyl]-2-[3-...)
Affinity DataKi: >1.00E+5nMAssay Description:In vitro inhibitory activity against thrombinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed